HOME >> BIOLOGY >> NEWS
First clinical study of new pediatric croup vaccine shows safety, tolerability in adults

Scientists at St. Jude Children's Research Hospital are investigating in adults the use of a vaccine given by nose drops that might ultimately protect children against human parainfluenza virus-type 1 (hPIV-1). This virus is the most common cause of croup, a pediatric respiratory disease that causes almost 30,000 hospitalizations each year and many more emergency room visits.

These findings are published in the current issue of Vaccine.

Successful development of an effective hPIV-1 vaccine would be significant because none is currently available and a vaccine that is given to infants using nose drops would eliminate the discomfort and complications of injections.

Because the vaccine contains a live virus, it should stimulate both antibody and cellular immune responses, which together may provide durable protection from hPIV-1. In cellular immunity, special cells, rather than antibodies, destroy virus-infected cells inside the body.

The vaccine consists of Sendai virus (SeV), a mouse virus that is similar enough to hPIV-1 to act as a vaccine, but different enough to have never been associated with a human disease, according to Karen Slobod, M.D., associate member of the department of Infectious Diseases.

Slobod is the lead author of the Vaccine report.

Pre-clinical studies by the St. Jude team proved that intranasal SeV vaccine can protect against the human croup virus. The results of the study in nine healthy adults demonstrated that the SeV vaccine was safe and well tolerated. None of those vaccinated experienced any significant reactions, such as respiratory symptoms or laboratory abnormalities.

This FDA-approved Phase I trial was initiated in adults as a first step, prior to future testing in children and then infants--the ultimate target population, said Jerry Shenep, M.D., member of the department of Infectious Diseases and a co-author of the paper.

"The St. Jude team based the vaccine on SeV for two reasons," sai
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
23-Aug-2004


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. 2nd media alert First Scientific Conference on Childhood Leukaemia
3. First International Scientific Conference on Childhood Leukaemia
4. First ever standards linking climate change, biodiversity and poverty seek global peer review
5. First genetic comparison of purebred domestic dogs produces surprises
6. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
7. First target for childhood malaria vaccine
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2019)... ... December 11, 2019 , ... Fiberstar, Inc., a ... beverage industry won the 2019 Food Ingredient Europe’s plant-based innovation award. , This ... plant-based foods category. Fiberstar who was one of three finalists achieved this award ...
(Date:12/4/2019)... ... December 04, 2019 , ... NDA Partners Chairman ... regulatory toxicology expert with more than 20 years of experience working in the ... Todd has extensive experience with a variety of biologic modalities including monoclonal antibodies, ...
(Date:11/27/2019)... Ellyn, IL (PRWEB) , ... November 26, 2019 ... ... Gibbs, invite patients to their Glen Ellyn, IL practice for Invisalign® ... straighten crooked teeth. , Patients with a misaligned bite, also known as malocclusion, ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... ... January 07, 2020 , ... ... services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in ... originally obtained from rats or hamsters, which Absolute Antibody has engineered into mouse-anti-mouse ...
(Date:1/7/2020)... SAN MATEO, CA (PRWEB) , ... January 06, ... ... Brilliant Smart Home Control, today announced its expansion into whole-home smart lighting with ... Brilliant Smart Dimmer Switch unlocks the ability for homeowners and homebuilders to affordably ...
(Date:12/31/2019)... ... December 31, 2019 , ... At this year's SLAS conference, Visikol ... broadly focused on 3D cell culture , advanced imaging and ... assays for assessing steatosis , inflammation and fibrosis as well as ...
(Date:12/27/2019)... ... December 27, 2019 , ... ... its 505(b)(2) product pipeline that offers patients and healthcare providers options ... concepts were identified in collaboration with doctors and managed care professionals and developed ...
Breaking Biology Technology:
Cached News: